Brain–computer interfacing

Tobii, Valve, and OpenBCI Engaging in Research Collaboration to Make VR Gaming More Immersive

Retrieved on: 
Thursday, February 4, 2021

OpenBCI is an advanced technology company providing an open-source platform for applications related to brain computer interfacing (BCI).

Key Points: 
  • OpenBCI is an advanced technology company providing an open-source platform for applications related to brain computer interfacing (BCI).
  • Valve, one of the most influential companies in the gaming industry, has long been a pioneering force for the evolution of immersive gaming, entertainment content delivery, and the advancement of virtual reality hardware and experiences.
  • It is the first device that integrates EEG, EMG, EOG, EDA, PPG, and image based eye-tracking into a single headset.
  • The Galea Beta units will be built with elements from the Valve Index VR hardware.

Can Brain Implants Improve Mobility After Stroke?

Retrieved on: 
Monday, February 1, 2021

When it happens, blood clots or bleeds kill a part of the brain it goes dark and can no longer control part of the body.

Key Points: 
  • When it happens, blood clots or bleeds kill a part of the brain it goes dark and can no longer control part of the body.
  • "This study serves as a proof of concept, a necessary bridge to future studies that would use fully implanted wireless electrodes to improve movement after stroke."
  • In those patients, electrodes that recorded brain signals were implanted in the brain tissue and connected by wires extending through the skull to a computer.
  • But those abilities were only available to the patients as long as the brain implants were in place.

Entheon Biomedical Partners with Divergence Neuro Technologies Inc. for Predictive Biomarker Platform Development

Retrieved on: 
Tuesday, January 19, 2021

Divergence will also develop a software platform (the "Application") that supports the tracking of EEG data during pre, intra, and post dosing using, among other prediction models, the DMT Biomarker Model.

Key Points: 
  • Divergence will also develop a software platform (the "Application") that supports the tracking of EEG data during pre, intra, and post dosing using, among other prediction models, the DMT Biomarker Model.
  • Entheon will utilize Divergence's expertise to consult on planning, research, and development of the DMT Biomarker Model and the Application to predict acute responses to DMT based on the analysis of EEG data.
  • Divergence will lead the process of integrating EEG into Entheon's DMT-therapy platform with the ultimate goal of incorporating the technology for use by any clinics utilizing DMT products for the treatment of substance use disorders.
  • About Divergence Neuro Technologies Inc.
    Divergence is a Toronto-based company focused on the research and development of a data-driven, cloud-based neuro platform based on EEG-analysis and machine learning to improve mental health for all.

New Research Firm, DecisionLabs, is First-Ever to Conduct Behavioral, Brain, and Field Testing Studies on B2B Buyer Interactions

Retrieved on: 
Thursday, December 17, 2020

Newly launched, DecisionLabs will focus on helping marketing, sales, and customer success departments improve buyer interactions and drive better commercial outcomes.

Key Points: 
  • Newly launched, DecisionLabs will focus on helping marketing, sales, and customer success departments improve buyer interactions and drive better commercial outcomes.
  • Brain Study Lab with complete EEG, ECG, GSR, Eye Tracking, and Facial Recognition equipment to determine subconscious response and impact.
  • Field Test functionality, including a new 10-person inside sales call center and a lab-in-a-box solution, to test real-world interactions and outcomes.
  • Unlike traditional market research and advisory firms, DecisionLabs conducts rigorous research studies based in several Decision Science disciplines:
    Behavioral research discover underlying buying motivations of B2B decision-makers.

New Research Firm, DecisionLabs, is First-Ever to Conduct Behavioral, Brain, and Field Testing Studies on B2B Buyer Interactions

Retrieved on: 
Thursday, December 17, 2020

Newly launched, DecisionLabs will focus on helping marketing, sales, and customer success departments improve buyer interactions and drive better commercial outcomes.

Key Points: 
  • Newly launched, DecisionLabs will focus on helping marketing, sales, and customer success departments improve buyer interactions and drive better commercial outcomes.
  • Brain Study Lab with complete EEG, ECG, GSR, Eye Tracking, and Facial Recognition equipment to determine subconscious response and impact.
  • Field Test functionality, including a new 10-person inside sales call center and a lab-in-a-box solution, to test real-world interactions and outcomes.
  • Unlike traditional market research and advisory firms, DecisionLabs conducts rigorous research studies based in several Decision Science disciplines:
    Behavioral research discover underlying buying motivations of B2B decision-makers.

Conscious Labs Supplies Dry Active Sensors to OpenBCI, Inc.

Retrieved on: 
Thursday, December 17, 2020

Neurotechnology startup Conscious Labs supplied ThinkPulse, its dry active electro-encephalography (EEG) electrode system, to OpenBCI, Inc. for its market-leading UltraCortex headset.

Key Points: 
  • Neurotechnology startup Conscious Labs supplied ThinkPulse, its dry active electro-encephalography (EEG) electrode system, to OpenBCI, Inc. for its market-leading UltraCortex headset.
  • ThinkPulse is an active EEG sensor system delivering research-grade signal quality with the comfort of a consumer-grade product.
  • Thanks to flexible polymeric dry sensors, it is designed to conveniently augment the standard electrode set of the Ultracortex and enhance the user experience, allowing long recording sessions.
  • Julien Dauguet, PhD, co-founder and CEO of Conscious Labs: ThinkPulse has been crafted with R&D engineers, hackers and makers in mind.

Stratus Strengthens its Commitment to Environmental Safety by Installing Synexis Biodefense System at Texas Headquarters

Retrieved on: 
Monday, December 14, 2020

IRVING, Texas, Dec. 14, 2020 /PRNewswire-PRWeb/ -- Stratus, the nation's leading provider of in-home video electroencephalogram (EEG) testing, has enhanced their commitment to keeping its environment safe through the installation of the Synexis Biodefense System at their Texas headquarters.

Key Points: 
  • IRVING, Texas, Dec. 14, 2020 /PRNewswire-PRWeb/ -- Stratus, the nation's leading provider of in-home video electroencephalogram (EEG) testing, has enhanced their commitment to keeping its environment safe through the installation of the Synexis Biodefense System at their Texas headquarters.
  • Stratus always adheres to the highest patient care and safety standards in the industry, which is backed by a Joint Commission accreditation.
  • "Our technology provides peace of mind for the Stratus team because it's working 24-7-365 in their environment," said Eric Schlote, CEO of Synexis, LLC.
  • The Synexis system is UL Certified to produce no ozone and works continuously without disruptions in normal operations or workflow.

Brain Scientific to Showcase Disposable EEG Headset NeuroCap™ at American Epilepsy Society Annual Meeting

Retrieved on: 
Friday, December 4, 2020

The American Epilepsy Society's Annual Meeting is the largest meeting and exhibition in the world to share common scientific and clinical interests in epilepsy and clinical neurophysiology.

Key Points: 
  • The American Epilepsy Society's Annual Meeting is the largest meeting and exhibition in the world to share common scientific and clinical interests in epilepsy and clinical neurophysiology.
  • We will be showing the new version of our disposable NeuroCap with Velcro elements to hundreds of specialists from around the world.
  • The next generation NeuroCap is a hospital-grade disposable EEG headset with 19 active EEG channels.
  • The American Epilepsy Society Annual Meeting is a premier national gathering of healthcare professionals who treat and research epilepsy.

Brain Scientific Files Patent Application For New Long-Term Monitoring EEG Cap

Retrieved on: 
Wednesday, December 2, 2020

During EEG testing electrodes are put to the persons head by either a cap application or placement of each electrode.

Key Points: 
  • During EEG testing electrodes are put to the persons head by either a cap application or placement of each electrode.
  • Additionally, when an electrode cap is used for EEG, customizing it to fit users remains a challenge due to the various head sizes.
  • The new EEG product for which Brain Scientific is seeking a patent approval is a flexible head cap for conducting electroencephalography.
  • Traditionally, EEG tests have been useful in helping diagnose conditions relating to brain injuries, such as seizures, strokes, brain tumors, Alzheimers disease and certain psychoses.

Neural Implants Market - Global Outlook and Forecast Report 2020-2025 - Key Players are Medtronic, Abbott, Boston Scientific, NEVRO, and LivaNova

Retrieved on: 
Monday, November 23, 2020

DUBLIN, Nov. 23, 2020 /PRNewswire/ -- The "Neural Implants Market - Global Outlook and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Nov. 23, 2020 /PRNewswire/ -- The "Neural Implants Market - Global Outlook and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering.
  • The neural implants market by revenue is expected to grow at a CAGR of 11% during the period 2020-2025.
  • The global brain implants market is one of the fastest-growing segments in the global neurological treatment devices industry.
  • In 2019, the spinal cord stimulation (SCS) segment accounted for more than 62% of the global neural implants market share.